Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a ... in the next few months. Medtronic is part of ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Shares of Medtronic PLC MDT slumped 0.56% to $88.13 Wednesday, on what proved to be an all-around dismal trading session for ...

Kuehne+Nagel announced the opening of a new, temperature-controlled fulfilment centre for its partner Medtronic. The global ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

There will continue to be a dire need for products that help simplify the lives of these patients. Medtronic is one of the more prominent companies in this niche, which could provide it with a ...

Management cited an across-the-board performance in products from cardiac pacing therapies, cardiac surgery, defibrillation solutions, and coronary solutions. In terms of guidance, Medtronic now ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Medtronic (MDT – Research Report), with a ...